Guardant Health, Inc. (NASDAQ:GH) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET
Company Participants
Zarak Khurshid – Vice President of Investor Relations
Helmy Eltoukhy – Chairman and Co-Chief Executive Officer
AmirAli Talasaz – Co-Chief Executive Officer
Michael Bell – Chief Financial Officer
Conference Call Participants
Mark Massaro – BTIG
Tycho Peterson – Jefferies
Bill Bonello – Craig-Hallum
Subbu Nambi – Guggenheim Partners
Puneet Souda – Leerink Partners
Dan Leonard – UBS
Dan Brennan – TD Cowen
Rachel Vatnsdal – JPMorgan
Luke Sergott – Barclays
Operator
Hello, everybody and welcome to the Guardant Health Q1 2025 Earnings Call. My name is Elliot, and I will be your coordinator today. [Operator Instructions]
I would now like to hand over to, Zarak Khurshid, Vice President of Investor Relations. Please go ahead.
Zarak Khurshid
Thank you. Earlier today, Guardant Health released financial results for the quarter ended March 31, 2025. Joining me today from Guardant are Helmy Eltoukhy, Co-CEO; AmirAli Talasaz, Co-CEO; and Mike Bell, Chief Financial Officer.
Before we begin, I’d like to remind you that during this call, management will make forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated.
This call will also include a discussion of non-GAAP financial measures, which are adjusted to exclude certain specified items. Additional information regarding material risks and uncertainties, as well as the non-GAAP financial reconciliation to most directly comparable GAAP financial measures are available in the press release Guardant issued today, as well as in our 10-K and other filings with the SEC.
Guardant disclaims any intention or obligation to update or revise financial projections and forward-looking statements whether because of new information, future events or otherwise except as required by law. The
#Guardant #Health #Earnings #Call #Transcript